ARK Genomic Revolution ETF (ARKG)Health | Exchange Traded Fund | Cboe US
31.00 USD
+1.16
(3.898%)
⇧
(April 17, 2026, 11:45 a.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★★☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 11, 2026, 3:25 p.m. EDT
ARKG has shown a volatile price trend in recent days, with significant fluctuations around the 27.00 mark. The recent news about advancements in gene editing and biotech ETFs could provide some momentum, but the lack of consistent dividend payouts and the overall mixed options activity suggest caution. While there is potential for short-term gains, the long-term fundamentals and the current market conditions make it a risky investment. Investors should monitor the ETF's performance closely and consider the broader market trends before making any decisions. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.096304 |
| AutoETS | 0.098595 |
| AutoTheta | 0.098717 |
| AutoARIMA | 0.099808 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 10.55 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.572 |
| Excess Kurtosis | -0.73 |
As of April 11, 2026, 3:25 p.m. EDT: Options speculators are showing mixed signals. There is a concentration of open interest (OI) and volume around strikes slightly above the current price, suggesting some bullish sentiment. However, there are also significant puts with high OI and IV at lower strikes, indicating potential bearish expectations. The overall options activity suggests uncertainty, with traders hedging against both upward and downward movements. The presence of high IV at certain strikes indicates that there is a lot of speculation and volatility expected in the near term.
| Date | Dividend | Yield % |
|---|---|---|
| 2021-12-29 | 0.382 | 0.636031 |
| 2020-12-29 | 0.790 | 0.844557 |
| 2019-12-27 | 1.054 | 3.104725 |
| 2018-12-27 | 0.466 | 2.107597 |
| 2017-12-27 | 0.328 | 1.413498 |
| Attribute | Value |
|---|---|
| All Time High | 115.15 |
| All Time Low | 15.001 |
| Ask | 31.0 |
| Ask Size | 300 |
| Average Daily Volume10 Day | 2,169,430 |
| Average Daily Volume3 Month | 2,816,837 |
| Average Volume | 2,816,837 |
| Average Volume10Days | 2,169,430 |
| Beta3 Year | 2.53 |
| Bid | 30.99 |
| Bid Size | 300 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 31.215 |
| Day Low | 30.521 |
| Dividend Yield | 0.0 |
| Esg Populated | 0 |
| Exchange | BTS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 27.9875 |
| Fifty Day Average Change | 3.0145016 |
| Fifty Day Average Change Percent | 0.10770886 |
| Fifty Two Week Change Percent | 46.059715 |
| Fifty Two Week High | 34.39 |
| Fifty Two Week High Change | -3.3879986 |
| Fifty Two Week High Change Percent | -0.09851697 |
| Fifty Two Week Low | 20.21 |
| Fifty Two Week Low Change | 10.792002 |
| Fifty Two Week Low Change Percent | 0.5339932 |
| Fifty Two Week Range | 20.21 - 34.39 |
| First Trade Date Milliseconds | 1,414,762,200,000 |
| Five Year Average Return | -0.1947582 |
| Full Exchange Name | Cboe US |
| Fund Family | ARK ETF Trust |
| Fund Inception Date | 1,414,713,600 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified. |
| Long Name | ARK Genomic Revolution ETF |
| Market | us_market |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_268203657 |
| Nav Price | 29.868 |
| Net Assets | 1,042,499,970.0 |
| Net Expense Ratio | 0.75 |
| Open | 30.6 |
| Phone | 212-426-7040 |
| Previous Close | 29.84 |
| Price Hint | 2 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | 1.1620007 |
| Regular Market Change Percent | 3.8976307 |
| Regular Market Day High | 31.215 |
| Regular Market Day Low | 30.521 |
| Regular Market Day Range | 30.521 - 31.215 |
| Regular Market Open | 30.6 |
| Regular Market Previous Close | 29.84 |
| Regular Market Price | 31.002 |
| Regular Market Time | 1,776,440,748 |
| Regular Market Volume | 1,319,814 |
| Short Name | ARK Genomic Revolution ETF |
| Source Interval | 15 |
| Symbol | ARKG |
| Three Year Average Return | -0.0051957 |
| Total Assets | 1,042,499,968 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | -8.56659 |
| Trailing Three Month Returns | -8.56659 |
| Triggerable | 1 |
| Two Hundred Day Average | 28.159525 |
| Two Hundred Day Average Change | 2.842476 |
| Two Hundred Day Average Change Percent | 0.1009419 |
| Type Disp | ETF |
| Volume | 1,319,814 |
| Yield | 0.0 |
| Ytd Return | -8.56659 |